Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure

LC Ling, TY Chang, YJ Lin, CY Lin… - Journal of …, 2024 - Wiley Online Library
Background Previous research has demonstrated that atrial fibrillation (AF) ablation
improves heart function variably among patients. We proposed that the ANTWERP score …

A comprehensive meta-analysis comparing radiofrequency ablation versus pharmacological therapy for the treatment of atrial fibrillation in patients with heart failure

M Casula, L Pignalosa, F Quilico, LV Scajola… - International Journal of …, 2023 - Elsevier
Background Atrial fibrillation (AF) and heart failure (HF) are both associated with worse
prognosis and often coexist in the same patients. Whether catheter ablation (CA) is superior …

Atrial fibrillation ablation in heart failure patients: Where do we stand in 2023?–State of the art review

TF Deering, SK Goyal, AA Bhimani… - Pacing and Clinical …, 2024 - Wiley Online Library
Atrial fibrillation (AF) and heart failure are common overlapping cardiovascular disorders.
Despite important therapeutic advances over the past several decades, controversy persists …

Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failure

Z Zhao, Y Wang, C Jiang, Z Yang, J Zhang, Y Lai… - Heart Rhythm, 2024 - Elsevier
Background The impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial
fibrillation (AF) recurrence outcomes and adverse cardiovascular outcomes in heart failure …

[HTML][HTML] Value of Imaging in the Non-Invasive Prediction of Recurrence after Catheter Ablation in Patients with Atrial Fibrillation: An Up-to-Date Review

M Jing, D Li, H Xi, Y Zhang, J Zhou - Reviews in Cardiovascular …, 2023 - imrpress.com
Catheter ablation (CA) is the first-line treatment for atrial fibrillation (AF) patients. However,
the risk of recurrence associated with CA treatment should not be ignored. Therefore, the …

[HTML][HTML] 2023 National Heart Center/Saudi Heart Association Focused Update of the 2019 Saudi Heart Association Guidelines for the Management of Heart Failure

W Al Habeeb, A Tash, A Elasfar… - Journal of the Saudi …, 2023 - ncbi.nlm.nih.gov
Background The burden of cardiovascular diseases is undeniable in local populations, who
have high mortality rates and a young age of disease onset. A systematic review of …

High power short duration versus low power long duration ablation in patients with atrial fibrillation: A meta‐analysis of randomized trials

A Parlavecchio, G Vetta, G Coluccia… - Pacing and Clinical …, 2023 - Wiley Online Library
Background High‐power‐short‐duration (HPSD) radiofrequency (RF) ablation is a viable
alternative to low‐power‐long‐duration (LPLD) RF for pulmonary vein isolation (PVI) …

[HTML][HTML] Catheter ablation in patients with paroxysmal atrial fibrillation and absence of structural heart disease: A meta-analysis of randomized trials

A Parlavecchio, G Vetta, G Coluccia, L Pistelli… - IJC Heart & …, 2023 - Elsevier
Introduction Rhythm control strategy in paroxysmal atrial fibrillation (AF) can be performed
with antiarrhythmic drugs (AAD) or catheter ablation (CA). Nevertheless, a clear overview of …

Atrial Fibrillation Associated with Heart Failure: Perspectives from Recent Large Clinical Studies and Translational Research

SA Bentounes, A Bisson, L Fauchier - Journal of Clinical Medicine, 2023 - mdpi.com
Atrial fibrillation (AF) is a major public health issue. In 2010, there were 20.9 million men and
12.6 million women worldwide who had AF. The estimated incidence rates were, in 100,000 …

Atrial fibrillation in heart failure: drugs or ablation?

F Palmas, C Noviello, M Bo - European Heart Journal …, 2023 - academic.oup.com
Atrial fibrillation (AF) and heart failure (HF) frequently coexist and mutually exert negative
influences with important clinical implications. Although there is evidence that restoring and …